EDGAR Filing Documents for 0000899243-22-021804

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000899243-22-021804

Filing Date

2022-06-10

Accepted

2022-06-10 07:30:22

Documents

Period of Report

2022-06-08

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	4011
	Complete submission text file	0000899243-22-021804.txt		5755

Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453

Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600

Viridian Therapeutics, Inc.\DE (Issuer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address 79 TW ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709

Business Address

Type: 4 | Act: 34 | File No.: 001-36483 | Film No.: 221007635